NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,844 | -2.5% | 145,731 | -3.4% | 3.48% | +5.3% |
| Q2 2023 | $15,224 | +7.2% | 150,871 | -2.2% | 3.31% | +5.2% |
| Q1 2023 | $14,195 | -1.2% | 154,293 | -2.6% | 3.14% | -0.1% |
| Q4 2022 | $14,370 | -99.9% | 158,397 | -1.5% | 3.15% | +2.6% |
| Q3 2022 | $12,221,000 | -10.6% | 160,779 | -0.5% | 3.07% | -0.8% |
| Q2 2022 | $13,666,000 | -8.0% | 161,665 | -4.5% | 3.09% | +6.7% |
| Q1 2022 | $14,862,000 | -0.2% | 169,371 | -0.5% | 2.90% | +9.7% |
| Q4 2021 | $14,889,000 | +8.8% | 170,223 | +1.7% | 2.64% | -1.1% |
| Q3 2021 | $13,688,000 | -11.4% | 167,378 | -1.2% | 2.67% | -9.7% |
| Q2 2021 | $15,449,000 | +4.1% | 169,328 | -2.5% | 2.96% | +4.6% |
| Q1 2021 | $14,842,000 | -20.1% | 173,631 | -11.7% | 2.83% | -18.6% |
| Q4 2020 | $18,574,000 | +10.7% | 196,693 | +1.9% | 3.48% | -0.4% |
| Q3 2020 | $16,785,000 | +2.8% | 193,021 | +3.3% | 3.49% | +21.9% |
| Q2 2020 | $16,327,000 | +5.5% | 186,940 | -0.4% | 2.86% | -30.1% |
| Q1 2020 | $15,470,000 | -13.3% | 187,633 | -0.5% | 4.10% | +23.1% |
| Q4 2019 | $17,852,000 | +12.4% | 188,534 | +3.2% | 3.33% | -1.0% |
| Q3 2019 | $15,879,000 | -8.6% | 182,729 | -3.9% | 3.36% | -8.5% |
| Q2 2019 | $17,364,000 | -19.4% | 190,164 | -15.2% | 3.67% | -7.9% |
| Q1 2019 | $21,551,000 | +8.0% | 224,161 | -3.6% | 3.99% | -2.2% |
| Q4 2018 | $19,949,000 | +0.8% | 232,481 | +1.2% | 4.08% | +10.3% |
| Q3 2018 | $19,794,000 | +15.2% | 229,736 | +1.0% | 3.70% | +12.2% |
| Q2 2018 | $17,176,000 | -6.3% | 227,371 | +0.3% | 3.29% | -9.5% |
| Q1 2018 | $18,324,000 | -4.3% | 226,636 | -0.6% | 3.64% | +4.4% |
| Q4 2017 | $19,145,000 | -4.2% | 228,028 | -2.1% | 3.48% | -4.7% |
| Q3 2017 | $19,989,000 | -2.4% | 232,833 | -5.1% | 3.66% | -6.7% |
| Q2 2017 | $20,484,000 | +10.8% | 245,403 | -1.4% | 3.92% | +9.6% |
| Q1 2017 | $18,489,000 | +4.3% | 248,938 | +2.3% | 3.58% | +5.4% |
| Q4 2016 | $17,728,000 | +3.4% | 243,388 | +12.1% | 3.40% | -6.1% |
| Q3 2016 | $17,148,000 | +19.2% | 217,173 | +48.4% | 3.62% | +12.2% |
| Q2 2016 | $14,388,000 | +16.9% | 146,312 | -13.9% | 3.22% | +19.4% |
| Q1 2016 | $12,308,000 | -14.1% | 169,907 | +2.0% | 2.70% | -16.7% |
| Q4 2015 | $14,335,000 | +6.5% | 166,609 | +13.8% | 3.24% | +0.1% |
| Q3 2015 | $13,461,000 | -7.5% | 146,439 | -1.0% | 3.24% | +2.8% |
| Q2 2015 | $14,549,000 | -7.5% | 147,942 | -7.3% | 3.15% | -7.1% |
| Q1 2015 | $15,732,000 | +5.5% | 159,542 | -0.9% | 3.39% | +8.6% |
| Q4 2014 | $14,918,000 | +3.7% | 160,992 | +5.4% | 3.12% | -4.2% |
| Q3 2014 | $14,384,000 | +0.1% | 152,812 | -3.8% | 3.26% | +3.0% |
| Q2 2014 | $14,374,000 | +5.6% | 158,777 | -0.8% | 3.17% | +1.8% |
| Q1 2014 | $13,607,000 | +2.3% | 160,040 | -3.3% | 3.11% | +0.5% |
| Q4 2013 | $13,303,000 | +5.7% | 165,507 | +0.9% | 3.10% | -3.0% |
| Q3 2013 | $12,589,000 | +10.3% | 164,108 | +1.7% | 3.19% | +6.6% |
| Q2 2013 | $11,410,000 | – | 161,362 | – | 2.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |